Production (Stage)
Amneal Pharmaceuticals, Inc.
AMRX
$7.16
-$0.03-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.18% | 19.92% | -16.07% | -58.08% | -67.26% |
| Total Receivables | 13.67% | 25.23% | 7.53% | 12.56% | 20.62% |
| Inventory | 5.39% | 5.34% | 3.45% | 4.55% | 7.87% |
| Prepaid Expenses | -21.77% | -6.08% | 2.93% | 35.04% | 28.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.15% | 4.01% | -50.00% | 10.48% | -20.30% |
| Total Current Assets | 9.45% | 15.24% | 3.93% | 4.48% | 5.56% |
|
|
|||||
| Total Current Assets | 9.45% | 15.24% | 3.93% | 4.48% | 5.56% |
| Net Property, Plant & Equipment | -4.05% | -4.81% | -4.98% | -7.41% | -5.81% |
| Long-term Investments | -0.18% | -0.20% | -0.05% | -0.11% | -0.10% |
| Goodwill | -0.18% | -0.20% | -0.05% | -0.11% | -0.10% |
| Total Other Intangibles | -19.80% | -17.75% | -20.59% | -19.25% | -18.58% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.54% | 31.39% | 24.67% | 80.47% | 39.72% |
| Total Assets | -2.64% | 0.83% | -6.13% | -5.16% | -4.69% |
|
|
|||||
| Total Accounts Payable | 9.66% | 78.55% | 33.55% | 44.62% | 29.25% |
| Total Accrued Expenses | 10.55% | 24.92% | 16.00% | 16.39% | 32.50% |
| Short-term Debt | 62.01% | -44.13% | 84.21% | 49.17% | 79.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.27% | 394.11% | 418.19% | 486.63% | 9.73% |
| Total Finance Division Other Current Liabilities | 47.41% | -2.23% | -9.97% | -20.02% | -21.18% |
| Total Other Current Liabilities | 47.41% | -2.23% | -9.97% | -20.02% | -21.18% |
| Total Current Liabilities | 28.94% | 33.45% | 43.99% | 43.35% | 18.57% |
|
|
|||||
| Total Current Liabilities | 28.94% | 33.45% | 43.99% | 43.35% | 18.57% |
| Long-Term Debt | -10.98% | -10.94% | -16.00% | -15.92% | -7.00% |
| Short-term Debt | 62.01% | -44.13% | 84.21% | 49.17% | 79.00% |
| Capital Leases | -9.83% | -4.56% | -5.36% | -6.44% | -8.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.02% | 291.01% | 156.62% | 160.60% | 130.62% |
| Total Liabilities | -1.39% | 3.95% | -0.03% | -0.11% | 0.25% |
|
|
|||||
| Common Stock & APIC | 1.32% | 3.87% | -22.57% | -22.85% | -23.01% |
| Retained Earnings | -2.24% | -23.85% | -47.11% | -43.52% | -40.83% |
| Treasury Stock & Other | -261.60% | -102.51% | -2,005.03% | -476.54% | -729.94% |
| Total Common Equity | -106.62% | -652.38% | -128.24% | -118.06% | -121.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -106.62% | -652.38% | -128.24% | -118.06% | -121.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 53.40% | 55.89% | 142.84% | 139.47% | 135.64% |
| Total Equity | -257.61% | -172.65% | -117.60% | -102.22% | -110.24% |
|
|
|||||